Clinical Trial: A Prospective, Open-Label, Single-Arm, Phase Ib/II Study of Neoadjuvant Propranolol Combined With SOX Chemotherapy and Toripalimab in Patients With Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (China)

China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Open-Label, Single-Arm, Phase Ib/II Study of Neoadjuvant Propranolol Combined With SOX Chemotherapy and Toripalimab in Patients With Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131905

Registration Time: 2026/09/07

Type: Interventional study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338635

Published by HT Digital Content Services with permission from Health Daily Digest....